Evaluate Safety and Tolerability of RX001 in Patients With KRAS Mutant Advanced NSCLC

Clinical trial NCT06934590 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06934590
Sponsor: GeneCraft Inc.
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Non-Small Cell Lung Cancer

Start date: 2025-05-01
Primary completion: 2026-09-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.